microRNA information: hsa-miR-374a-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-374a-3p | miRbase |
Accession: | MIMAT0004688 | miRbase |
Precursor name: | hsa-mir-374a | miRbase |
Precursor accession: | MI0000782 | miRbase |
Symbol: | MIR374A | HGNC |
RefSeq ID: | NR_030785 | GenBank |
Sequence: | CUUAUCAGAUUGUAUUGUAAUU |
Reported expression in cancers: hsa-miR-374a-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-374a-3p | bladder cancer | deregulation | "By using high-throughput sequencing technologies w ......" | 23939156 | RNA-Seq |
hsa-miR-374a-3p | breast cancer | upregulation | "MicroRNA 374a activates Wnt/β catenin signaling t ......" | 23321667 | |
hsa-miR-374a-3p | gastric cancer | upregulation | "In this study we found that miR-374a expression wa ......" | 25554419 | |
hsa-miR-374a-3p | lung cancer | downregulation | "Aberrant expression of miR-374a has been reported ......" | 27207663 | |
hsa-miR-374a-3p | lung squamous cell cancer | downregulation | "Identification of miR 374a as a prognostic marker ......" | 21748820 | Microarray |
hsa-miR-374a-3p | sarcoma | upregulation | "Furthermore the upregulated miRNAs included miR-9/ ......" | 23133552 | |
hsa-miR-374a-3p | sarcoma | upregulation | "In the present study we reported that the expressi ......" | 26064239 | |
hsa-miR-374a-3p | sarcoma | upregulation | "MicroRNA-374a miR-374a has been implicated in seve ......" | 26617789 | qPCR |
Reported cancer pathway affected by hsa-miR-374a-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-374a-3p | colon cancer | PI3K/Akt signaling pathway; cell cycle pathway; Epithelial mesenchymal transition pathway | "microRNA 374a suppresses colon cancer progression ......" | 27191497 | Luciferase |
hsa-miR-374a-3p | lung cancer | cell cycle pathway; Apoptosis pathway | "In this study we validate and report that miR-374a ......" | 24832599 |
Reported cancer prognosis affected by hsa-miR-374a-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-374a-3p | breast cancer | metastasis; poor survival | "MicroRNA 374a activates Wnt/β catenin signaling t ......" | 23321667 | |
hsa-miR-374a-3p | breast cancer | worse prognosis; progression | "Effects of differential distribution of microvesse ......" | 23679262 | Western blot |
hsa-miR-374a-3p | colon cancer | progression; metastasis | "microRNA 374a suppresses colon cancer progression ......" | 27191497 | Luciferase |
hsa-miR-374a-3p | colorectal cancer | progression | "Furthermore we found that miR-34a miR-34c miR-369- ......" | 26062441 | |
hsa-miR-374a-3p | esophageal cancer | progression; worse prognosis | "MicroRNA 374a promotes esophageal cancer cell prol ......" | 26252180 | |
hsa-miR-374a-3p | gastric cancer | malignant trasformation | "miR 374a promotes cell proliferation migration and ......" | 25554419 | |
hsa-miR-374a-3p | lung cancer | tumorigenesis; poor survival | "In this study we validate and report that miR-374a ......" | 24832599 | |
hsa-miR-374a-3p | lung squamous cell cancer | staging; poor survival; progression | "Identification of miR 374a as a prognostic marker ......" | 21748820 | |
hsa-miR-374a-3p | ovarian cancer | drug resistance | "MiR 130a and MiR 374a Function as Novel Regulators ......" | 26043084 | Western blot |
Reported gene related to hsa-miR-374a-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-374a-3p | esophageal cancer | AXIN2 | "MicroRNA 374a promotes esophageal cancer cell prol ......" | 26252180 |
hsa-miR-374a-3p | sarcoma | AXIN2 | "MiR 374a promotes the proliferation of osteosarcom ......" | 26617789 |
hsa-miR-374a-3p | lung cancer | AXL | "Of clinical significance high expression of Axl an ......" | 24832599 |
hsa-miR-374a-3p | colon cancer | CCND1 | "microRNA 374a suppresses colon cancer progression ......" | 27191497 |
hsa-miR-374a-3p | sarcoma | FOXO1 | "MiR 374a promotes the proliferation of human osteo ......" | 26064239 |
hsa-miR-374a-3p | colorectal cancer | LDHA | "More importantly we identified a genetic loci newl ......" | 26062441 |
hsa-miR-374a-3p | gastric cancer | SRCIN1 | "miR 374a promotes cell proliferation migration and ......" | 25554419 |
hsa-miR-374a-3p | lung cancer | TGFA | "MiR 374a suppresses lung adenocarcinoma cell proli ......" | 27207663 |
hsa-miR-374a-3p | breast cancer | VCAM1 | "Our data demonstrated miR-374a to be differentiall ......" | 23679262 |
hsa-miR-374a-3p | breast cancer | VEGFA | "Our data demonstrated miR-374a to be differentiall ......" | 23679262 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-374a-3p | RAB3GAP1 | 10 cancers: BLCA; BRCA; ESCA; HNSC; LGG; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.113; TCGA BRCA -0.077; TCGA ESCA -0.133; TCGA HNSC -0.137; TCGA LGG -0.051; TCGA PAAD -0.136; TCGA PRAD -0.13; TCGA SARC -0.221; TCGA STAD -0.108; TCGA UCEC -0.079 |
hsa-miR-374a-3p | PTPRG | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LUAD; PRAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.208; TCGA BRCA -0.204; TCGA ESCA -0.248; TCGA HNSC -0.253; TCGA KIRP -0.255; TCGA LGG -0.152; TCGA LUAD -0.112; TCGA PRAD -0.293; TCGA STAD -0.183 |
hsa-miR-374a-3p | PCMTD1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.142; TCGA BRCA -0.141; TCGA CESC -0.153; TCGA ESCA -0.154; TCGA HNSC -0.103; TCGA KIRC -0.264; TCGA KIRP -0.133; TCGA SARC -0.328; TCGA STAD -0.204 |
hsa-miR-374a-3p | PRICKLE2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.464; TCGA BRCA -0.295; TCGA COAD -0.257; TCGA HNSC -0.21; TCGA LGG -0.173; TCGA LIHC -0.268; TCGA LUAD -0.13; TCGA PRAD -0.331; TCGA SARC -0.438; TCGA STAD -0.519 |
hsa-miR-374a-3p | BMPR2 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LUAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.241; TCGA BRCA -0.118; TCGA ESCA -0.169; TCGA HNSC -0.2; TCGA LGG -0.187; TCGA LUAD -0.086; TCGA PRAD -0.09; TCGA SARC -0.138; TCGA STAD -0.233 |
hsa-miR-374a-3p | PARD3B | 10 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.417; TCGA BRCA -0.385; TCGA CESC -0.399; TCGA KIRC -0.851; TCGA KIRP -0.47; TCGA LGG -0.202; TCGA LUAD -0.198; TCGA PRAD -0.407; TCGA SARC -0.566; TCGA STAD -0.199 |
hsa-miR-374a-3p | ZHX3 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.217; TCGA CESC -0.127; TCGA ESCA -0.19; TCGA HNSC -0.144; TCGA KIRC -0.505; TCGA KIRP -0.171; TCGA LUAD -0.139; TCGA PRAD -0.081; TCGA SARC -0.173; TCGA STAD -0.249; TCGA UCEC -0.128 |
hsa-miR-374a-3p | ZC3H6 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LGG; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.212; TCGA BRCA -0.251; TCGA CESC -0.15; TCGA ESCA -0.197; TCGA KIRC -0.101; TCGA KIRP -0.287; TCGA LGG -0.148; TCGA SARC -0.208; TCGA STAD -0.327; TCGA UCEC -0.113 |
hsa-miR-374a-3p | ZMAT3 | 9 cancers: BLCA; BRCA; COAD; HNSC; LGG; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.256; TCGA BRCA -0.164; TCGA COAD -0.235; TCGA HNSC -0.208; TCGA LGG -0.323; TCGA PRAD -0.335; TCGA SARC -0.198; TCGA THCA -0.197; TCGA STAD -0.319 |
hsa-miR-374a-3p | PCYOX1 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.094; TCGA BRCA -0.186; TCGA CESC -0.086; TCGA HNSC -0.158; TCGA KIRC -0.377; TCGA LUAD -0.1; TCGA PAAD -0.157; TCGA PRAD -0.109; TCGA SARC -0.109; TCGA STAD -0.164 |
hsa-miR-374a-3p | NEK7 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRP; PAAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.285; TCGA BRCA -0.209; TCGA CESC -0.166; TCGA HNSC -0.241; TCGA KIRP -0.094; TCGA PAAD -0.19; TCGA SARC -0.211; TCGA THCA -0.064; TCGA STAD -0.166 |
hsa-miR-374a-3p | GOLGA4 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.152; TCGA BRCA -0.215; TCGA CESC -0.184; TCGA ESCA -0.335; TCGA HNSC -0.161; TCGA KIRC -0.352; TCGA KIRP -0.21; TCGA LGG -0.073; TCGA PAAD -0.172; TCGA SARC -0.113; TCGA STAD -0.292 |
hsa-miR-374a-3p | MYO9A | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.287; TCGA BRCA -0.238; TCGA CESC -0.263; TCGA ESCA -0.189; TCGA HNSC -0.254; TCGA KIRC -0.282; TCGA KIRP -0.485; TCGA LGG -0.231; TCGA LUAD -0.08; TCGA PAAD -0.303; TCGA PRAD -0.319; TCGA SARC -0.512; TCGA STAD -0.306 |
hsa-miR-374a-3p | RASAL2 | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.276; TCGA CESC -0.126; TCGA ESCA -0.179; TCGA HNSC -0.198; TCGA KIRP -0.209; TCGA LGG -0.136; TCGA LUAD -0.069; TCGA PAAD -0.216; TCGA PRAD -0.133; TCGA SARC -0.142; TCGA THCA -0.113; TCGA UCEC -0.124 |
hsa-miR-374a-3p | PLXNA2 | 9 cancers: BLCA; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.287; TCGA LGG -0.2; TCGA LIHC -0.158; TCGA LUAD -0.238; TCGA LUSC -0.301; TCGA PAAD -0.319; TCGA PRAD -0.298; TCGA SARC -0.215; TCGA STAD -0.197 |
hsa-miR-374a-3p | NEBL | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.324; TCGA BRCA -0.245; TCGA HNSC -0.259; TCGA KIRC -0.918; TCGA KIRP -0.632; TCGA LUAD -0.143; TCGA PAAD -0.35; TCGA PRAD -0.121; TCGA UCEC -0.397 |
hsa-miR-374a-3p | ERC1 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.194; TCGA BRCA -0.065; TCGA COAD -0.1; TCGA HNSC -0.223; TCGA KIRC -0.227; TCGA LGG -0.057; TCGA LUAD -0.059; TCGA PRAD -0.213; TCGA SARC -0.216; TCGA STAD -0.149 |
hsa-miR-374a-3p | MIB1 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.105; TCGA BRCA -0.089; TCGA HNSC -0.138; TCGA KIRC -0.354; TCGA KIRP -0.182; TCGA LGG -0.194; TCGA PAAD -0.176; TCGA SARC -0.179; TCGA STAD -0.137; TCGA UCEC -0.09 |
hsa-miR-374a-3p | NFAT5 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.179; TCGA BRCA -0.114; TCGA CESC -0.129; TCGA HNSC -0.203; TCGA KIRC -0.393; TCGA KIRP -0.314; TCGA PRAD -0.089; TCGA SARC -0.126; TCGA STAD -0.209 |
hsa-miR-374a-3p | GLIS3 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.318; TCGA CESC -0.297; TCGA COAD -0.487; TCGA HNSC -0.233; TCGA KIRC -0.394; TCGA KIRP -0.304; TCGA PRAD -0.414; TCGA SARC -0.337; TCGA STAD -0.346 |
hsa-miR-374a-3p | GAB1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.256; TCGA BRCA -0.157; TCGA ESCA -0.183; TCGA HNSC -0.233; TCGA KIRC -0.21; TCGA KIRP -0.105; TCGA PRAD -0.136; TCGA SARC -0.202; TCGA STAD -0.162 |
hsa-miR-374a-3p | LNPEP | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.185; TCGA BRCA -0.319; TCGA CESC -0.161; TCGA ESCA -0.184; TCGA HNSC -0.249; TCGA KIRC -0.451; TCGA KIRP -0.252; TCGA PAAD -0.245; TCGA PRAD -0.194; TCGA SARC -0.324; TCGA STAD -0.31 |
hsa-miR-374a-3p | CPEB4 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.335; TCGA BRCA -0.247; TCGA CESC -0.319; TCGA HNSC -0.379; TCGA KIRC -0.466; TCGA LGG -0.237; TCGA LUSC -0.129; TCGA PRAD -0.163; TCGA SARC -0.492; TCGA STAD -0.127 |
hsa-miR-374a-3p | BBX | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.165; TCGA BRCA -0.166; TCGA COAD -0.067; TCGA HNSC -0.15; TCGA KIRC -0.271; TCGA KIRP -0.153; TCGA PRAD -0.199; TCGA SARC -0.169; TCGA STAD -0.264 |
hsa-miR-374a-3p | RIMS3 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; LIHC; LUSC; PRAD; SARC | mirMAP | TCGA BLCA -0.265; TCGA CESC -0.235; TCGA COAD -0.257; TCGA HNSC -0.51; TCGA KIRC -0.406; TCGA LIHC -0.183; TCGA LUSC -0.406; TCGA PRAD -0.28; TCGA SARC -0.86 |
hsa-miR-374a-3p | SGIP1 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; SARC; STAD | mirMAP | TCGA BLCA -0.281; TCGA COAD -0.23; TCGA ESCA -0.361; TCGA HNSC -0.221; TCGA KIRC -0.41; TCGA KIRP -0.391; TCGA LGG -0.118; TCGA LUAD -0.16; TCGA SARC -0.585; TCGA STAD -0.369 |
hsa-miR-374a-3p | FAM63B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.297; TCGA BRCA -0.333; TCGA CESC -0.235; TCGA COAD -0.165; TCGA ESCA -0.185; TCGA HNSC -0.339; TCGA KIRC -0.646; TCGA KIRP -0.451; TCGA LUAD -0.072; TCGA PAAD -0.398; TCGA PRAD -0.235; TCGA SARC -0.586; TCGA STAD -0.344 |
hsa-miR-374a-3p | PRKAB2 | 10 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; PAAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.249; TCGA BRCA -0.079; TCGA ESCA -0.176; TCGA KIRC -0.233; TCGA KIRP -0.151; TCGA LGG -0.128; TCGA PAAD -0.125; TCGA SARC -0.334; TCGA STAD -0.251; TCGA UCEC -0.096 |
hsa-miR-374a-3p | VPS13B | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; SARC; STAD | mirMAP | TCGA BLCA -0.153; TCGA BRCA -0.152; TCGA CESC -0.162; TCGA ESCA -0.125; TCGA HNSC -0.193; TCGA KIRP -0.216; TCGA LGG -0.12; TCGA LUAD -0.052; TCGA SARC -0.278; TCGA STAD -0.148 |
hsa-miR-374a-3p | IL6ST | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.544; TCGA BRCA -0.677; TCGA CESC -0.443; TCGA COAD -0.189; TCGA HNSC -0.438; TCGA KIRC -0.253; TCGA KIRP -0.476; TCGA PRAD -0.68; TCGA SARC -0.632; TCGA STAD -0.215 |
hsa-miR-374a-3p | SECISBP2L | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; SARC; STAD | mirMAP | TCGA BLCA -0.175; TCGA BRCA -0.159; TCGA CESC -0.163; TCGA ESCA -0.154; TCGA HNSC -0.181; TCGA KIRC -0.292; TCGA KIRP -0.221; TCGA LGG -0.076; TCGA SARC -0.201; TCGA STAD -0.154 |
hsa-miR-374a-3p | PDPK1 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; SARC; STAD | mirMAP | TCGA BLCA -0.118; TCGA BRCA -0.152; TCGA CESC -0.231; TCGA HNSC -0.152; TCGA KIRC -0.183; TCGA KIRP -0.162; TCGA LGG -0.152; TCGA LUAD -0.076; TCGA SARC -0.233; TCGA STAD -0.085 |
hsa-miR-374a-3p | EXOC6B | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.255; TCGA BRCA -0.285; TCGA HNSC -0.449; TCGA KIRC -0.392; TCGA KIRP -0.237; TCGA LGG -0.175; TCGA PAAD -0.427; TCGA PRAD -0.392; TCGA SARC -0.6; TCGA STAD -0.264 |
hsa-miR-374a-3p | RBMS3 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LUAD; PRAD; STAD | mirMAP | TCGA BLCA -0.346; TCGA BRCA -0.219; TCGA COAD -0.314; TCGA HNSC -0.209; TCGA KIRP -0.295; TCGA LGG -0.222; TCGA LUAD -0.138; TCGA PRAD -0.538; TCGA STAD -0.385 |
hsa-miR-374a-3p | FBXL17 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; STAD; UCEC | mirMAP | TCGA BLCA -0.122; TCGA BRCA -0.288; TCGA CESC -0.118; TCGA ESCA -0.206; TCGA HNSC -0.114; TCGA KIRC -0.284; TCGA LGG -0.206; TCGA STAD -0.148; TCGA UCEC -0.115 |
hsa-miR-374a-3p | EGFR | 9 cancers: BLCA; HNSC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.473; TCGA HNSC -0.471; TCGA KIRP -0.315; TCGA LGG -0.363; TCGA LUSC -0.24; TCGA PAAD -0.488; TCGA PRAD -0.345; TCGA SARC -0.231; TCGA STAD -0.299 |
hsa-miR-374a-3p | FER | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.245; TCGA BRCA -0.211; TCGA HNSC -0.261; TCGA KIRC -0.302; TCGA KIRP -0.199; TCGA PAAD -0.326; TCGA PRAD -0.229; TCGA SARC -0.117; TCGA STAD -0.269 |
hsa-miR-374a-3p | ADAMTS5 | 9 cancers: BLCA; BRCA; ESCA; KIRP; LGG; LUSC; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.226; TCGA BRCA -0.157; TCGA ESCA -0.385; TCGA KIRP -0.583; TCGA LGG -0.493; TCGA LUSC -0.24; TCGA PRAD -0.483; TCGA STAD -0.234; TCGA UCEC -0.221 |
hsa-miR-374a-3p | RAPGEF6 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.21; TCGA BRCA -0.308; TCGA CESC -0.339; TCGA ESCA -0.128; TCGA HNSC -0.351; TCGA KIRP -0.343; TCGA PRAD -0.279; TCGA SARC -0.482; TCGA STAD -0.192 |
hsa-miR-374a-3p | TAOK1 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.237; TCGA BRCA -0.306; TCGA CESC -0.245; TCGA ESCA -0.17; TCGA HNSC -0.365; TCGA KIRC -0.318; TCGA KIRP -0.369; TCGA LGG -0.266; TCGA PAAD -0.415; TCGA PRAD -0.432; TCGA SARC -0.453; TCGA STAD -0.158 |
hsa-miR-374a-3p | KIAA1161 | 9 cancers: BLCA; CESC; ESCA; KIRC; LGG; LUAD; PAAD; PRAD; SARC | mirMAP | TCGA BLCA -0.337; TCGA CESC -0.23; TCGA ESCA -0.306; TCGA KIRC -0.713; TCGA LGG -0.381; TCGA LUAD -0.119; TCGA PAAD -0.325; TCGA PRAD -0.459; TCGA SARC -0.558 |
hsa-miR-374a-3p | ANO5 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.588; TCGA BRCA -0.471; TCGA COAD -0.448; TCGA ESCA -0.649; TCGA KIRC -1.6; TCGA LGG -0.466; TCGA PRAD -0.328; TCGA SARC -1.002; TCGA STAD -0.519 |
hsa-miR-374a-3p | ALS2CL | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; SARC; STAD | mirMAP | TCGA BLCA -0.265; TCGA CESC -0.381; TCGA ESCA -0.297; TCGA HNSC -0.166; TCGA KIRC -1.012; TCGA KIRP -0.355; TCGA LIHC -0.334; TCGA LUAD -0.178; TCGA SARC -0.339; TCGA STAD -0.213 |
hsa-miR-374a-3p | ANKFY1 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; THCA | mirMAP | TCGA BLCA -0.116; TCGA BRCA -0.121; TCGA CESC -0.102; TCGA COAD -0.114; TCGA HNSC -0.102; TCGA KIRC -0.183; TCGA KIRP -0.105; TCGA LUAD -0.067; TCGA THCA -0.072 |
hsa-miR-374a-3p | FMN1 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.391; TCGA BRCA -0.48; TCGA CESC -0.43; TCGA ESCA -0.577; TCGA HNSC -0.469; TCGA KIRC -0.879; TCGA KIRP -0.419; TCGA PAAD -0.415; TCGA PRAD -0.244; TCGA SARC -0.753; TCGA STAD -0.192 |
hsa-miR-374a-3p | FAM126B | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; SARC; STAD | miRNATAP | TCGA BLCA -0.102; TCGA BRCA -0.071; TCGA ESCA -0.186; TCGA HNSC -0.198; TCGA KIRC -0.19; TCGA KIRP -0.131; TCGA LGG -0.272; TCGA SARC -0.118; TCGA STAD -0.194 |
hsa-miR-374a-3p | ARHGEF12 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.125; TCGA BRCA -0.189; TCGA CESC -0.187; TCGA ESCA -0.185; TCGA HNSC -0.207; TCGA KIRC -0.265; TCGA KIRP -0.223; TCGA LGG -0.068; TCGA LUAD -0.072; TCGA PAAD -0.14; TCGA PRAD -0.147; TCGA SARC -0.186; TCGA STAD -0.167 |
hsa-miR-374a-3p | AFF4 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; PAAD; SARC; STAD | miRNATAP | TCGA BLCA -0.155; TCGA BRCA -0.283; TCGA CESC -0.163; TCGA ESCA -0.176; TCGA HNSC -0.261; TCGA KIRP -0.114; TCGA LGG -0.099; TCGA LUAD -0.05; TCGA PAAD -0.176; TCGA SARC -0.203; TCGA STAD -0.219 |
hsa-miR-374a-3p | PEG3 | 10 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.669; TCGA BRCA -0.229; TCGA COAD -0.495; TCGA KIRC -1.094; TCGA KIRP -0.358; TCGA LGG -0.225; TCGA LUAD -0.139; TCGA PRAD -0.208; TCGA SARC -0.62; TCGA STAD -0.568 |
hsa-miR-374a-3p | UHMK1 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; PAAD; PRAD; SARC | miRNATAP | TCGA BLCA -0.227; TCGA BRCA -0.351; TCGA CESC -0.305; TCGA HNSC -0.33; TCGA KIRC -0.571; TCGA KIRP -0.424; TCGA PAAD -0.49; TCGA PRAD -0.467; TCGA SARC -0.433 |
hsa-miR-374a-3p | PLEKHH2 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.258; TCGA BRCA -0.202; TCGA COAD -0.421; TCGA ESCA -0.288; TCGA KIRC -0.338; TCGA KIRP -0.622; TCGA LGG -0.184; TCGA LUAD -0.163; TCGA PRAD -0.213; TCGA SARC -0.349; TCGA STAD -0.417 |
hsa-miR-374a-3p | MAGI1 | 11 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.281; TCGA ESCA -0.393; TCGA HNSC -0.161; TCGA KIRC -0.524; TCGA KIRP -0.416; TCGA LGG -0.275; TCGA LUAD -0.158; TCGA PAAD -0.271; TCGA PRAD -0.092; TCGA SARC -0.521; TCGA STAD -0.162 |
hsa-miR-374a-3p | FBXL2 | 10 cancers: BRCA; CESC; COAD; HNSC; KIRC; LIHC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.178; TCGA CESC -0.261; TCGA COAD -0.404; TCGA HNSC -0.218; TCGA KIRC -0.442; TCGA LIHC -0.374; TCGA PAAD -0.24; TCGA PRAD -0.256; TCGA SARC -0.208; TCGA STAD -0.248 |
hsa-miR-374a-3p | OXR1 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BRCA -0.14; TCGA CESC -0.147; TCGA ESCA -0.193; TCGA HNSC -0.124; TCGA KIRC -0.198; TCGA KIRP -0.382; TCGA LGG -0.175; TCGA PAAD -0.182; TCGA PRAD -0.101; TCGA SARC -0.241; TCGA THCA -0.072 |
hsa-miR-374a-3p | PPP2R5E | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; PRAD; SARC; STAD | MirTarget | TCGA BRCA -0.108; TCGA ESCA -0.138; TCGA HNSC -0.199; TCGA KIRC -0.237; TCGA KIRP -0.167; TCGA LGG -0.121; TCGA PRAD -0.128; TCGA SARC -0.149; TCGA STAD -0.134 |
hsa-miR-374a-3p | RAB11FIP2 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LGG; PRAD; SARC; STAD; UCEC | mirMAP; miRNATAP | TCGA BRCA -0.152; TCGA HNSC -0.09; TCGA KIRC -0.361; TCGA KIRP -0.246; TCGA LGG -0.244; TCGA PRAD -0.126; TCGA SARC -0.118; TCGA STAD -0.132; TCGA UCEC -0.174 |
hsa-miR-374a-3p | SBNO1 | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; PRAD; SARC; STAD | mirMAP | TCGA BRCA -0.186; TCGA CESC -0.256; TCGA HNSC -0.283; TCGA KIRC -0.286; TCGA KIRP -0.263; TCGA LGG -0.138; TCGA PRAD -0.306; TCGA SARC -0.42; TCGA STAD -0.165 |
hsa-miR-374a-3p | VPS53 | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; STAD | mirMAP | TCGA BRCA -0.071; TCGA CESC -0.086; TCGA COAD -0.127; TCGA ESCA -0.1; TCGA HNSC -0.091; TCGA KIRC -0.191; TCGA LGG -0.099; TCGA LIHC -0.083; TCGA LUAD -0.078; TCGA STAD -0.158 |
hsa-miR-374a-3p | GATAD2B | 10 cancers: BRCA; CESC; KIRC; KIRP; LGG; LUAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.108; TCGA CESC -0.074; TCGA KIRC -0.08; TCGA KIRP -0.112; TCGA LGG -0.128; TCGA LUAD -0.066; TCGA PRAD -0.101; TCGA SARC -0.205; TCGA STAD -0.167; TCGA UCEC -0.066 |
hsa-miR-374a-3p | ZNF704 | 9 cancers: BRCA; CESC; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC | mirMAP | TCGA BRCA -0.196; TCGA CESC -0.371; TCGA HNSC -0.24; TCGA KIRC -0.366; TCGA LGG -0.213; TCGA LUAD -0.125; TCGA PAAD -0.291; TCGA PRAD -0.278; TCGA SARC -0.393 |
hsa-miR-374a-3p | LONRF2 | 9 cancers: BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; SARC; STAD | mirMAP | TCGA BRCA -0.619; TCGA COAD -1.032; TCGA KIRC -1.47; TCGA KIRP -0.488; TCGA LGG -0.301; TCGA LIHC -0.61; TCGA LUAD -0.185; TCGA SARC -1.646; TCGA STAD -0.567 |
hsa-miR-374a-3p | WIPF2 | 9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC | mirMAP | TCGA BRCA -0.207; TCGA CESC -0.151; TCGA HNSC -0.195; TCGA KIRC -0.087; TCGA KIRP -0.146; TCGA LUAD -0.055; TCGA PAAD -0.147; TCGA PRAD -0.148; TCGA SARC -0.131 |
hsa-miR-374a-3p | LCOR | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC | mirMAP | TCGA BRCA -0.305; TCGA CESC -0.351; TCGA ESCA -0.166; TCGA HNSC -0.313; TCGA KIRC -0.397; TCGA KIRP -0.449; TCGA LGG -0.239; TCGA PAAD -0.431; TCGA PRAD -0.209; TCGA SARC -0.273 |
hsa-miR-374a-3p | RBM27 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BRCA -0.156; TCGA CESC -0.14; TCGA ESCA -0.123; TCGA HNSC -0.18; TCGA KIRC -0.078; TCGA KIRP -0.147; TCGA LGG -0.071; TCGA PAAD -0.128; TCGA PRAD -0.078; TCGA SARC -0.093; TCGA STAD -0.064 |
hsa-miR-374a-3p | ATP9A | 11 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; UCEC | miRNATAP | TCGA BRCA -0.102; TCGA CESC -0.172; TCGA HNSC -0.199; TCGA KIRC -0.511; TCGA KIRP -0.147; TCGA LGG -0.295; TCGA LIHC -0.156; TCGA PAAD -0.308; TCGA PRAD -0.134; TCGA SARC -0.51; TCGA UCEC -0.094 |
hsa-miR-374a-3p | RPRD1A | 9 cancers: BRCA; HNSC; KIRC; KIRP; LGG; PAAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.118; TCGA HNSC -0.088; TCGA KIRC -0.212; TCGA KIRP -0.079; TCGA LGG -0.17; TCGA PAAD -0.177; TCGA SARC -0.281; TCGA THCA -0.051; TCGA UCEC -0.065 |
Enriched cancer pathways of putative targets